SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tara Cobble who wrote (32)6/19/1997 7:06:00 PM
From: R Tapp   of 320
 
Hi Tara:

I'm adding ARNX shares to my buy list and will be recommending these shares to my clients tomorrow. As of the close today, these shares are down over 62% since 9/9/96 and are now trading at 1.4 times book. The company appears to have good fundamentals, prudent strategic alliances, and 4 exciting products in various stages of FDA testing with more in the pipeline.

I see very little downside here and tremendous upside for investors with a bit of patience.

Regards,

RTapp
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News